Medicenna Therapeutics Corp. Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2023-12-22: Form 6-K; Period of report 2023-12-21; Description FORM 6-K; Document f6k_122223.htm.
- 2023-12-22: Form 6-K; Period of report 2023-12-19; Description FORM 6-K; Document f6k_122223.htm.
- 2023-11-21: Form 6-K; Period of report 2023-11-17; Description FORM 6-K; Document tm2331073d1_6k.htm.
- 2023-11-14: Form 6-K; Period of report 2023-09-30; Description FORM 6-K; Document f6k_110923.htm.